Trial Profile
A Randomised, Controlled Phase IV Clinical Trial With an Inactivated Influenza Vaccine(Split Virion).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2013
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Hualan Biological Engineering
- 13 Aug 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
- 25 Jan 2012 New trial record